Growth Factor-Mediated Induction of HDM2 Positively Regulates Hypoxia-Inducible Factor 1α Expression

REFERENCES

• Alvarez-Tejado, M., Alfranca A., Aragones J., Vara A., Landazuri M. O., and del Peso L.. 2002. Lack of evidence for the involvement of the phosphoinositide 3-kinase/Akt pathway in the activation of hypoxia-inducible factors by low oxygen tension. J. Biol. Chem. 277:13508–13517.
   PubMedGoogle Scholar
• Arany, Z., Huang L. E., Eckner R., Bhattacharya S., Jiang C., Goldberg M. A., Bunn H. F., and Livingston D. M.. 1996. An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. Acad. Sci. USA 93:12969–12973.
   PubMed Web of Science ®Google Scholar
• Arsham, A. M., Plas D. R., Thompson C. B., and Simon M. C.. 2002. Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription. J. Biol. Chem. 277:15162–15170.
   PubMed Web of Science ®Google Scholar
• Ashcroft, M., Ludwig R. L., Woods D. B., Copeland T. D., Weber H. O., MacRae E. J., and Vousden K. H.. 2002. Phosphorylation of HDM2 by Akt. Oncogene 21:1955–1962.
   PubMed Web of Science ®Google Scholar
• Ashcroft, M., Taya Y., and Vousden K. H.. 2000. Stress signals utilize multiple pathways to stabilize p53. Mol. Cell. Biol. 20:3224–3233.
   PubMed Web of Science ®Google Scholar
• Blagosklonny, M. V., An W. G., Romanova L. Y., Trepel J., Fojo T., and Neckers L.. 1998. p53 inhibits hypoxia-inducible factor-stimulated transcription. J. Biol. Chem. 273:11995–11998.
   PubMed Web of Science ®Google Scholar
• Blancher, C., Moore J. W., Robertson N., and Harris A. L.. 2001. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res. 61:7349–7355.
   PubMed Web of Science ®Google Scholar
• Bunz, F., Hwang P. M., Torrance C., Waldman T., Zhang Y., Dillehay L., Williams J., Lengauer C., Kinzler K. W., and Vogelstein B.. 1999. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Investig. 104:263–269.
   PubMed Web of Science ®Google Scholar
• Chan, D. A., Sutphin P. D., Denko N. C., and Giaccia A. J.. 2002. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J. Biol. Chem. 277:40112–40117.
   PubMed Web of Science ®Google Scholar
• Cockman, M. E., Masson N., Mole D. R., Jaakkola P., Chang G. W., Clifford S. C., Maher E. R., Pugh C. W., Ratcliffe P. J., and Maxwell P. H.. 2000. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275:25733–25741.
   PubMed Web of Science ®Google Scholar
• Dubs-Poterszman, M. C., Tocque B., and Wasylyk B.. 1995. MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest. Oncogene 11:2445–2449.
   PubMed Web of Science ®Google Scholar
• Franke, T. F., Yang S. I., Chan T. O., Datta K., Kazlauskas A., Morrison D. K., Kaplan D. R., and Tsichlis P. N.. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727–736.
   PubMed Web of Science ®Google Scholar
• Fukuda, R., Hirota K., Fan F., Jung Y. D., Ellis L. M., and Semenza G. L.. 2002. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277:38205–38211.
   PubMed Web of Science ®Google Scholar
• Gross, T. S., Akeno N., Clemens T. L., Komarova S., Srinivasan S., Weimer D. A., and Mayorov S.. 2001. Selected contribution: osteocytes upregulate HIF-1alpha in response to acute disuse and oxygen deprivation. J. Appl. Physiol. 90:2514–2519.
   PubMed Web of Science ®Google Scholar
• Harris, A. L. 2002. Hypoxia—a key regulatory factor in tumour growth. Nat. Rev. Cancer 2:38–47.
   PubMed Web of Science ®Google Scholar
• Hudson, C. C., Liu M., Chiang G. G., Otterness D. M., Loomis D. C., Kaper F., Giaccia A. J., and Abraham R. T.. 2002. Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin. Mol. Cell. Biol. 22:7004–7014.
   PubMed Web of Science ®Google Scholar
• Ivan, M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J. M., Lane W. S., and Kaelin W. G., Jr. 2001. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292:464–468.
   PubMed Web of Science ®Google Scholar
• Jaakkola, P., Mole D. R., Tian Y. M., Wilson M. I., Gielbert J., Gaskell S. J., Kriegsheim A., Hebestreit H. F., Mukherji M., Schofield C. J., Maxwell P. H., Pugh C. W., and Ratcliffe P. J.. 2001. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468–472.
   PubMed Web of Science ®Google Scholar
• Jeong, J. W., Bae M. K., Ahn M. Y., Kim S. H., Sohn T. K., Bae M. H., Yoo M. A., Song E. J., Lee K. J., and Kim K. W.. 2002. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 111:709–720.
   PubMed Web of Science ®Google Scholar
• Jiang, B. H., Zheng J. Z., Leung S. W., Roe R., and Semenza G. L.. 1997. Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J. Biol. Chem. 272:19253–19260.
   PubMed Web of Science ®Google Scholar
• Laughner, E., Taghavi P., Chiles K., Mahon P. C., and Semenza G. L.. 2001. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21:3995–4004.
   PubMed Web of Science ®Google Scholar
• Lohrum, M. A., Ashcroft M., Kubbutat M. H., and Vousden K. H.. 2000. Identification of a cryptic nucleolar-localization signal in MDM2. Nat. Cell Biol. 2:179–181.
   PubMed Web of Science ®Google Scholar
• Marechal, V., Elenbaas B., Piette J., Nicolas J. C., and Levine A. J.. 1994. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell. Biol. 14:7414–7420.
   PubMed Web of Science ®Google Scholar
• Maxwell, P. H., Wiesener M. S., Chang G. W., Clifford S. C., Vaux E. C., Cockman M. E., Wykoff C. C., Pugh C. W., Maher E. R., and Ratcliffe P. J.. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275.
   PubMed Web of Science ®Google Scholar
• Mayo, L. D., Dixon J. E., Durden D. L., Tonks N. K., and Donner D. B.. 2002. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J. Biol. Chem. 277:5484–5489.
   PubMed Web of Science ®Google Scholar
• Mayo, L. D., and Donner D. B.. 2001. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl. Acad. Sci. USA 98:11598–11603.
   PubMed Web of Science ®Google Scholar
• Mottet, D., Dumont V., Deccache Y., Demazy C., Ninane N., Raes M., and Michiels C.. 2003. Regulation of HIF-1alpha protein level during hypoxic conditions by the PI3K/AKT/GSK3beta pathway in HepG2 cells. J. Biol. Chem. 33:31277–31286.
   Google Scholar
• Pennacchietti, S., Michieli P., Galluzzo M., Mazzone M., Giordano S., and Comoglio P. M.. 2003. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3:347–361.
   PubMed Web of Science ®Google Scholar
• Phillips, A. C., Ernst M. K., Bates S., Rice N. R., and Vousden K. H.. 1999. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol. Cell 4:771–781.
   PubMedGoogle Scholar
• Polsky, D., Melzer K., Hazan C., Panageas K. S., Busam K., Drobnjak M., Kamino H., Spira J. G., Kopf A. W., Houghton A., Cordon-Cardo C., and Osman I.. 2002. HDM2 protein overexpression and prognosis in primary malignant melanoma. J. Natl. Cancer Inst. 94:1803–1806.
   PubMedGoogle Scholar
• Ravi, R., Mookerjee B., Bhujwalla Z. M., Sutter C. H., Artemov D., Zeng Q., Dillehay L. E., Madan A., Semenza G. L., and Bedi A.. 2000. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 14:34–44.
   PubMed Web of Science ®Google Scholar
• Ries, S., Biederer C., Woods D., Shifman O., Shirasawa S., Sasazuki T., McMahon M., Oren M., and McCormick F.. 2000. Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell 103:321–330.
   PubMed Web of Science ®Google Scholar
• Seger, Y. R., Garcia-Cao M., Piccinin S., Cunsolo C. L., Doglioni C., Blasco M. A., Hannon G. J., and Maestro R.. 2002. Transformation of normal human cells in the absence of telomerase activation. Cancer Cell 2:401–413.
   PubMed Web of Science ®Google Scholar
• Semenza, G. L. 2002. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8:S62–S67.
   PubMed Web of Science ®Google Scholar
• Treins, C., Giorgetti-Peraldi S., Murdaca J., Semenza G. L., and Van Obberghen E.. 2002. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J. Biol. Chem. 277:27975–27981.
   PubMed Web of Science ®Google Scholar
• Vousden, K. H. 2002. Activation of the p53 tumor suppressor protein. Biochim. Biophys. Acta 1602:47–59.
   PubMed Web of Science ®Google Scholar
• Yu, F., White S. B., Zhao Q., and Lee F. S.. 2001. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA 98:9630–9635.
   PubMed Web of Science ®Google Scholar
• Zhou, B. P., Liao Y., Xia W., Zou Y., Spohn B., and Hung M. C.. 2001. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell Biol. 3:973–982.
   PubMed Web of Science ®Google Scholar
• Zundel, W., Schindler C., Haas-Kogan D., Koong A., Kaper F., Chen E., Gottschalk A. R., Ryan H. E., Johnson R. S., Jefferson A. B., Stokoe D., and Giaccia A. J.. 2000. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14:391–396.
   PubMed Web of Science ®Google Scholar